Casas Juan P, Shah Tina, Cooper Jackie, Hawe Emma, McMahon Alex D, Gaffney Dairena, Packard Christopher J, O'Reilly Denis S, Juhan-Vague Irene, Yudkin John S, Tremoli Elena, Margaglione Maurizio, Di Minno Giovanni, Hamsten Anders, Kooistra Teake, Stephens Jeffrey W, Hurel Steven J, Livingstone Shona, Colhoun Helen M, Miller George J, Bautista Leonelo E, Meade Tom, Sattar Naveed, Humphries Steve E, Hingorani Aroon D
Centre for Clinical Pharmacology, Department of Medicine, BHF Laboratories at University College London, UCL, London, UK.
Int J Epidemiol. 2006 Aug;35(4):922-31. doi: 10.1093/ije/dyl041. Epub 2006 Mar 24.
It is unclear wheather the association between C-reactive protein (CRP) and incident coronary events is free from bias and confounding. Individuals homozygous for a +1444C>T polymorphism in the CRP gene have higher circulating concentrations of CRP. Since the distribution of this polymorphism occurs at random during gamete formation, its association with coronary events should not be biased or confounded.
We calculated the weighted mean difference in CRP between individuals with variants of the +1444C>T polymorphism in the CRP gene among 4,659 European men from six studies (genotype-intermediate phenotype studies). We used this difference together with data from previous observational studies to compute an expected odds ratio (OR) for non-fatal myocardial infarction (MI) among individuals homozygous for the T allele. We then performed four new genetic association studies (6,201 European men) to obtain a summary OR for the association between the +1444C>T polymorphism and non-fatal MI (genotype-disease studies).
CRP was 0.68 mg/l [95% confidence interval (95% CI) 0.31-1.10; P = 0.0001] higher among subjects homozygous for the +1444-T allele, with no confounding by a range of covariates. The expected ORs among TT subjects for non-fatal MI corresponding to this difference in CRP was 1.20 (95% CI 1.07-1.38) using the Reykjavik Heart study data and 1.25 (1.09-1.43) for all observational studies to 2004. The estimate for the observed adjusted-OR for non-fatal MI among TT subjects was 1.01 (95% CI 0.74-1.38), lower than both expected ORs.
A common CRP gene polymorphism is associated with important differences in CRP concentrations, free from confounding. The null association of this variant with coronary events suggests possible residual confounding (or reverse causation) in the CRP-coronary event association in observational studies, though the confidence limits are still compatible with a modest causal effect. Additional studies of genotype (or haplotype) and coronary events would help clarify whether or not the link between CRP and coronary events in observational studies is causal.
C反应蛋白(CRP)与冠心病事件之间的关联是否不受偏倚和混杂因素影响尚不清楚。CRP基因中+1444C>T多态性的纯合个体具有较高的循环CRP浓度。由于这种多态性的分布在配子形成过程中是随机发生的,其与冠心病事件的关联不应存在偏倚或混杂。
我们计算了来自六项研究的4659名欧洲男性中CRP基因+1444C>T多态性变体个体之间CRP的加权平均差异(基因型-中间表型研究)。我们将此差异与先前观察性研究的数据一起用于计算T等位基因纯合个体中非致命性心肌梗死(MI)的预期比值比(OR)。然后我们进行了四项新的基因关联研究(6201名欧洲男性),以获得+1444C>T多态性与非致命性MI之间关联的汇总OR(基因型-疾病研究)。
+1444-T等位基因纯合受试者的CRP水平高0.68mg/l[95%置信区间(95%CI)0.31-1.10;P=0.0001],不受一系列协变量的混杂影响。利用雷克雅未克心脏研究数据,对应于CRP这一差异的TT受试者中非致命性MI的预期OR为1.20(95%CI 1.07-1.38),到2004年所有观察性研究的预期OR为1.25(1.09-1.43)。TT受试者中非致命性MI的观察到的校正OR估计值为1.01(95%CI 0.74-1.38),低于两个预期OR。
一种常见的CRP基因多态性与CRP浓度的重要差异相关,不受混杂因素影响。该变体与冠心病事件之间无关联表明在观察性研究中CRP与冠心病事件关联中可能存在残余混杂(或反向因果关系),尽管置信区间仍与适度因果效应相符。对基因型(或单倍型)与冠心病事件的进一步研究将有助于阐明观察性研究中CRP与冠心病事件之间的联系是否具有因果关系。